J B Chemicals and Pharmaceuticals Ltd
NSE:JBCHEPHARM
J B Chemicals and Pharmaceuticals Ltd
NSE:JBCHEPHARM
Price:
1 593.2
INR
-0.45%
Market Cap:
248B
INR
Cash Flow Statement
Cash Flow Statement
J B Chemicals and Pharmaceuticals Ltd
J B Chemicals and Pharmaceuticals Ltd
Currency: INR
Millions
TTM
| Mar-2020 | Sep-2020 | Mar-2021 | Sep-2021 | Mar-2022 | Sep-2022 | Mar-2023 | Sep-2023 | Mar-2024 | Sep-2024 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | |||||||||||
| Net Income |
3 489
|
4 118
|
5 969
|
6 278
|
5 049
|
5 092
|
5 552
|
6 666
|
7 515
|
8 249
|
|
| Depreciation & Amortization |
663
|
689
|
687
|
675
|
727
|
933
|
1 144
|
1 237
|
1 383
|
1 574
|
|
| Other Non-Cash Items |
(584)
|
(542)
|
(1 148)
|
(1 038)
|
297
|
929
|
814
|
569
|
489
|
586
|
|
| Cash Taxes Paid |
908
|
1 003
|
1 417
|
1 707
|
1 346
|
1 108
|
955
|
1 082
|
1 325
|
1 652
|
|
| Cash Interest Paid |
19
|
63
|
64
|
25
|
25
|
137
|
322
|
432
|
442
|
262
|
|
| Change in Working Capital |
(811)
|
(2 475)
|
(2 359)
|
(2 128)
|
(4 371)
|
(3 831)
|
(1 254)
|
(791)
|
(1 381)
|
(2 843)
|
|
| Cash from Operating Activities |
2 758
N/A
|
1 790
-35%
|
3 148
+76%
|
3 786
+20%
|
1 701
-55%
|
3 122
+84%
|
6 256
+100%
|
7 681
+23%
|
8 006
+4%
|
7 566
-5%
|
|
| Investing Cash Flow | |||||||||||
| Capital Expenditures |
(730)
|
(608)
|
(478)
|
(591)
|
(7 068)
|
(10 501)
|
(7 649)
|
(4 792)
|
(2 614)
|
(2 173)
|
|
| Other Items |
969
|
1 718
|
(1 829)
|
(1 772)
|
7 091
|
6 200
|
(1 968)
|
(1 802)
|
(1 425)
|
157
|
|
| Cash from Investing Activities |
239
N/A
|
1 110
+364%
|
(2 307)
N/A
|
(2 363)
-2%
|
23
N/A
|
(4 301)
N/A
|
(9 618)
-124%
|
(6 594)
+31%
|
(4 038)
+39%
|
(2 016)
+50%
|
|
| Financing Cash Flow | |||||||||||
| Net Issuance of Common Stock |
(1 608)
|
(1 608)
|
0
|
0
|
0
|
46
|
85
|
123
|
200
|
188
|
|
| Net Issuance of Debt |
(24)
|
(64)
|
(78)
|
(80)
|
(84)
|
3 151
|
5 135
|
667
|
(2 043)
|
(3 593)
|
|
| Cash Paid for Dividends |
(1 410)
|
(929)
|
(732)
|
(1 294)
|
(1 276)
|
(1 332)
|
(1 276)
|
(1 374)
|
(1 570)
|
(1 901)
|
|
| Other |
(19)
|
(63)
|
(64)
|
(25)
|
(25)
|
(193)
|
(378)
|
(433)
|
(442)
|
(262)
|
|
| Cash from Financing Activities |
(3 061)
N/A
|
(2 664)
+13%
|
(874)
+67%
|
(1 399)
-60%
|
(1 384)
+1%
|
1 672
N/A
|
3 565
+113%
|
(1 017)
N/A
|
(3 855)
-279%
|
(5 568)
-44%
|
|
| Change in Cash | |||||||||||
| Effect of Foreign Exchange Rates |
(0)
|
(0)
|
0
|
1
|
0
|
0
|
0
|
(0)
|
(0)
|
0
|
|
| Net Change in Cash |
(64)
N/A
|
235
N/A
|
(33)
N/A
|
25
N/A
|
341
+1 262%
|
493
+45%
|
204
-59%
|
69
-66%
|
113
+63%
|
(17)
N/A
|
|
| Free Cash Flow | |||||||||||
| Free Cash Flow |
2 028
N/A
|
1 182
-42%
|
2 670
+126%
|
3 195
+20%
|
(5 367)
N/A
|
(7 379)
-37%
|
(1 393)
+81%
|
2 889
N/A
|
5 392
+87%
|
5 394
+0%
|
|
Switch to:
Switch to:
See Also
Discover More
You don't have any saved screeners yet
